Skip to main content

Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT)

Publication ,  Conference
Solanki, AA; Campbell, D; Carlson, K; Garraway, I; Henry, E; Jones, JA; Koppes, T; Newman, C; Quek, ML; Rettig, M; Ritter, T; Robin, L ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
2024

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2024

Volume

42

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Solanki, A. A., Campbell, D., Carlson, K., Garraway, I., Henry, E., Jones, J. A., … Nickols, N. G. (2024). Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).
Solanki, Abhishek A., Dara Campbell, Kimberly Carlson, Isla Garraway, Elizabeth Henry, Jeffrey A. Jones, Thomas Koppes, et al. “Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.
Solanki AA, Campbell D, Carlson K, Garraway I, Henry E, Jones JA, Koppes T, Newman C, Quek ML, Rettig M, Ritter T, Robin L, Salama JK, Skipworth A, Zacny E, Zheng K, Nickols NG. Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT). JOURNAL OF CLINICAL ONCOLOGY. 2024.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2024

Volume

42

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences